IGF1R and cancer: A further cancer vaccine study demonstrated that the VLPs, obtained by human parvovirus B19 chimeric VP2 proteins displaying two epitopes of the insulin-like growth factor-1 receptor (IGF-1R), were effective against breast cancer in the animal model.